Incorporated in 1984, Concord Biotech Limited is an India-based R&D-driven biopharma company. The company is ranked among the leading global developers and manufacturers of select fermentation-based APIs across immunosuppressants and oncology in terms of market share, based on volume in 2022.
Concord Biotech has a Global presence. They are supplying their products to over 70 countries including the USA, India, Europe, and Japan.
The company manufactures Active Pharmaceutical Ingredients (API) through fermentation & semi-synthetic process and finished formulations. It started with a single product and has grown to become a wide-spectrum solution provider.
Concord manufactures fermentation and semi-synthetic-based products in therapeutic segments such as Immunosuppressants, Anti-bacterial, Oncology, Antifungals & others. This wide range of products has attracted customers across the globe. Concord also has a robust pipeline of products under development.
Achieve the benefits of listing the Equity Shares on the Stock Exchanges and Carry out the Offer for Sale of up to 20,925,652 Equity Shares by the Selling Shareholder.
| IPO Opening Date | Aug 4, 2023 |
|---|---|
| IPO Closing Date | Aug 8, 2023 |
| Issue Type | Book Built Issue IPO |
| Face Value | ₹1 per share |
| IPO Price | ₹705 to ₹741 per share |
| Market Lot | 20 Shares |
| Min Order Quantity | 20 Shares |
| Listing At | BSE, NSE |
| Issue Size | 20,925,652 shares (aggregating up to ₹1,551.00 Cr) |
| Offer for Sale | 20,925,652 shares of ₹1 (aggregating up to ₹1,551.00 Cr) |
| Employee Discount | Rs 70 per share |
| QIB Shares Offered | Not more than 50% of the Net Issue |
| NII (HNI) Shares Offered | Not less than 15% of the Net Issue |
| Retail Shares Offered | Not less than 35% of the Net Issue |
| Basis of Allotment Date | 11 August 2023 |
|---|---|
| Initiation of Refunds | 14 August 2023 |
| Credit of Shares to Demat Account | 17 August 2023 |
| IPO Listing Date | 18 August 2023 |
Concord Biotech IPO is a main-board IPO of 20,925,652 equity shares of the face value of ₹1 aggregating up to ₹1,551.00 Crores. The issue is priced at ₹705 to ₹741 per share. The minimum order quantity is 20 Shares.
The IPO opens on Aug 4, 2023, and closes on Aug 8, 2023.
Link Intime India Private Ltd is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
The Concord Biotech IPO opens on Aug 4, 2023 and closes on Aug 8, 2023.
Concord Biotech IPO lot size is 20 Shares, and the minimum amount required is ₹14,820.
You can apply in Concord Biotech IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services.
The finalization of Basis of Allotment for Concord Biotech IPO will be done on Friday, 11 August 2023, and the allotted shares will be credited to your demat account by Thursday, 17 August 2023.
Check the IPO allotment status.
The Concord Biotech IPO listing date is 18 August 2023.
To Bid online, you need
Demat Account and Pan card.
Login to SMC account and
select the Concord Biotech IPO
Enter UPI Id & Mobile number
Place your number of bids
with the exchange
A UPI mandate is sent to your
UPI App to block your funds.
